Historical record - last NADAC effective date: 8/17/2022
Product Information
SERTRALINE HCL 25 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0394 per EA under NDC 16729021510. Its NADAC has been published 286 times since Mar 1, 2017.
FDA first approved this application on Nov 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729021510
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/17/2022
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202825FDA Approved
11/7/2014
TE Code
AB
On Market Since
2/9/2017
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE HCL 25 MG TABLET has been published 286 times since Mar 1, 2017, and over the history we have for it it has declined 35.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0394 per EA |
|---|---|
| All-time high | $0.0786 (Sep 16, 2020) |
| All-time low | $0.0394 (Aug 17, 2022) |
| Median price | $0.0611 |
| Average price | $0.0621 |
| Largest weekly change | +31.1% (Jul 22, 2020) |
| Weeks tracked | 286 |
| Tracking since | Mar 1, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-42.4%
All
-35.7%
Last surveyed Aug 17, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SERTRALINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE HCL 25 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0394 per EA (NDC 16729021510), effective Aug 17, 2022.
How has the price of SERTRALINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SERTRALINE HCL 25 MG TABLET has declined 35.7%. It has been tracked across 286 weekly CMS publications since Mar 1, 2017.
What are the highest and lowest recorded NADAC prices for SERTRALINE HCL 25 MG TABLET?
Since Mar 1, 2017, the NADAC for SERTRALINE HCL 25 MG TABLET has ranged from a low of $0.0394 (Aug 17, 2022) to a high of $0.0786 (Sep 16, 2020), with a median of $0.0611 per EA.
Are there cheaper alternatives to SERTRALINE HCL 25 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SERTRALINE HCL 25 MG TABLET, is $0.0298 per EA — about 24% below SERTRALINE HCL 25 MG TABLET.
Who manufactures SERTRALINE HCL 25 MG TABLET?
SERTRALINE HCL 25 MG TABLET (NDC 16729021510) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.